Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 99151-99200 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04671693
A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.
NA
Active, not recruiting
500 participants
Started: Dec 24, 2020 · Completed: Apr 24, 2029
9 conditions
8 sponsors
1 location
NCT05553015
A Real-World Registry Investigating TReprostInil sodiUM in Pulmonary Hypertension (Re-TRIUMPH)
N/A
Recruiting
450 participants
Started: Dec 24, 2020 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04620187
Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
PHASE2
Recruiting
55 participants
Started: Dec 24, 2020 · Completed: Feb 1, 2027
2 conditions
2 sponsors
12 locations
NCT04737239
Corticosteroid Injection Effectiveness in Carpel Tunnel Patients With Negative or Mild EMG Studies
N/A
Recruiting
300 participants
Started: Dec 23, 2020 · Completed: Dec 22, 2024
1 condition
1 sponsor
1 location
NCT04686253
Internal Microstructure of Patent Foramen Ovale Related to Stroke
N/A
Recruiting
1,200 participants
Started: Dec 23, 2020 · Completed: Dec 31, 2028
1 condition
6 sponsors
2 locations
NCT04789317
Pullback Pressure Gradient (PPG) Global Registry
N/A
Active, not recruiting
982 participants
Started: Dec 23, 2020 · Completed: Dec 31, 2026
2 conditions
1 sponsor
23 locations
NCT04373642
"QUAD SHOT Radiotherapy With Pembrolizumab in Patients With Recurrent Head & Neck Cancer"
PHASE2
Active, not recruiting
30 participants
Started: Dec 23, 2020 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT04584853
PreOperative Endocrine Therapy for Individualised Care With Abemaciclib
PHASE3
Recruiting
2,032 participants
Started: Dec 23, 2020 · Completed: Mar 31, 2032
1 condition
1 sponsor
62 locations
NCT04844242
MISC COVID-19 Study in Pediatric Population
N/A
Recruiting
180 participants
Started: Dec 23, 2020 · Completed: Dec 31, 2024
2 conditions
2 sponsors
1 location
NCT06336850
Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
NA
Recruiting
100 participants
Started: Dec 23, 2020 · Completed: Jan 1, 2025
1 condition
1 sponsor
1 location
NCT04586166
Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy
NA
Recruiting
180 participants
Started: Dec 23, 2020 · Completed: Dec 31, 2032
2 conditions
2 sponsors
7 locations
NCT06623539
Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver Disease
PHASE2
Active, not recruiting
360 participants
Started: Dec 23, 2020 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT04720326
Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients
PHASE4
Active, not recruiting
268 participants
Started: Dec 23, 2020 · Completed: Oct 31, 2026
1 condition
3 sponsors
15 locations
NCT04397185
Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer
NA
Recruiting
448 participants
Started: Dec 23, 2020 · Completed: Apr 30, 2025
1 condition
1 sponsor
26 locations
NCT03972956
Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease
N/A
Recruiting
1,000 participants
Started: Dec 23, 2020 · Completed: Dec 23, 2026
6 conditions
1 sponsor
1 location
NCT04961632
Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
PHASE1
Active, not recruiting
75 participants
Started: Dec 23, 2020 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT04842591
Characteristics of Pulmonary Vascular Changes in Patients With Kidney Transplantation
N/A
Active, not recruiting
60 participants
Started: Dec 23, 2020 · Completed: Dec 31, 2027
3 conditions
2 sponsors
1 location
NCT04523428
REtreatment With VEnetoclax and Acalabrutinib After Venetoclax Limited Duration (REVEAL)
PHASE2
Recruiting
60 participants
Started: Dec 23, 2020 · Completed: Dec 31, 2032
1 condition
1 sponsor
18 locations
NCT04828629
Complications and the Influence of COVID-19 on Myocardial Function and Exercise Capacity
N/A
Active, not recruiting
100 participants
Started: Dec 23, 2020 · Completed: Jan 1, 2025
2 conditions
1 sponsor
1 location
NCT04861415
SBRT vs. Conventional Fractionation With HDR Boost for Prostate Cancer
NA
Recruiting
55 participants
Started: Dec 23, 2020 · Completed: Dec 23, 2027
1 condition
1 sponsor
1 location
NCT06711211
Spanish Registry of Digestive Tumours RETUD
N/A
Recruiting
20,000 participants
Started: Dec 23, 2020 · Completed: Dec 31, 2030
6 conditions
1 sponsor
1 location
NCT06110416
Decreasing Post-Operative Nausea and Vomiting in the Bariatric Surgical Patient
NA
Recruiting
50 participants
Started: Dec 23, 2020 · Completed: Nov 23, 2024
2 conditions
1 sponsor
1 location
NCT04690374
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
N/A
Recruiting
250 participants
Started: Dec 22, 2020 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT04547504
PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %
PHASE3
Active, not recruiting
349 participants
Started: Dec 22, 2020 · Completed: Dec 22, 2025
1 condition
2 sponsors
29 locations
NCT04597164
Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF
N/A
Recruiting
200 participants
Started: Dec 22, 2020 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT04678895
Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy
PHASE2
Recruiting
35 participants
Started: Dec 22, 2020 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT04679142
Baclocur® Post-Authorisation Safety Study in Real-life Settings in France
N/A
Recruiting
975 participants
Started: Dec 22, 2020 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT04534127
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
NA
Recruiting
56 participants
Started: Dec 22, 2020 · Completed: Jan 1, 2026
3 conditions
1 sponsor
1 location
NCT04605770
Pemetrexed, Cisplatin With Soft Tissue Sarcoma
PHASE2
Recruiting
164 participants
Started: Dec 22, 2020 · Completed: Nov 1, 2027
1 condition
1 sponsor
1 location
NCT05359016
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
NA
Recruiting
14,600 participants
Started: Dec 22, 2020 · Completed: Feb 2, 2027
1 condition
4 sponsors
1 location
NCT04518592
Model-based Defining of Subtypes of Depression and Optimal Treatment: an Integrated Techniques Module.
N/A
Recruiting
300 participants
Started: Dec 22, 2020 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT05035667
Patient Considerations of Social Media Account Management After Death
N/A
Active, not recruiting
117 participants
Started: Dec 22, 2020 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT04794010
A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung Cancer
N/A
Active, not recruiting
825 participants
Started: Dec 22, 2020 · Completed: Dec 22, 2027
1 condition
1 sponsor
1 location
NCT04626024
Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population
PHASE2
Recruiting
100 participants
Started: Dec 22, 2020 · Completed: Nov 15, 2025
3 conditions
1 sponsor
4 locations
NCT04260867
Essential Oils for Electrocautery
NA
Active, not recruiting
111 participants
Started: Dec 22, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04375904
'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung)
PHASE2
Recruiting
68 participants
Started: Dec 22, 2020 · Completed: Feb 29, 2032
1 condition
3 sponsors
2 locations
NCT04583878
FUVID Study: Functional Characterization of Children With Chronic Venous Thromboembolic Disease
N/A
Recruiting
125 participants
Started: Dec 22, 2020 · Completed: Dec 31, 2026
2 conditions
1 sponsor
14 locations
NCT04564911
GLucose Monitoring Programme SingaporE, Phase 2 (GLiMPSE2)
NA
Active, not recruiting
206 participants
Started: Dec 22, 2020 · Completed: Dec 30, 2023
2 conditions
5 sponsors
3 locations
NCT04165083
KEYMAKER-U01 Substudy 2: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Treatment-naïve Participants With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Positive Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-01B/KEYMAKER-U01B)
PHASE2
Active, not recruiting
120 participants
Started: Dec 22, 2020 · Completed: Oct 31, 2025
1 condition
1 sponsor
39 locations
NCT04540588
Retreatment With Intratumoral Diffusing Alpha Radiation Emitters
NA
Recruiting
39 participants
Started: Dec 22, 2020 · Completed: Jan 1, 2026
3 conditions
1 sponsor
1 location
NCT04707248
A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors
PHASE1
Active, not recruiting
179 participants
Started: Dec 22, 2020 · Completed: Jun 30, 2026
2 conditions
2 sponsors
13 locations
NCT04526730
Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients
PHASE2
Active, not recruiting
17 participants
Started: Dec 22, 2020 · Completed: Jun 15, 2028
1 condition
2 sponsors
1 location
NCT04785534
Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis
NA
Active, not recruiting
1,000 participants
Started: Dec 22, 2020 · Completed: Aug 31, 2026
1 condition
2 sponsors
1 location
NCT04458324
Hybrid Functional Electrical Stimulation Exercise to Prevent Cardiopulmonary Declines in High-level Spinal Cord Injury
PHASE2
Recruiting
70 participants
Started: Dec 22, 2020 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT04898231
MIS-C Comparative Effectiveness Study
PHASE2/PHASE3
Active, not recruiting
73 participants
Started: Dec 22, 2020 · Completed: Jul 31, 2025
1 condition
2 sponsors
2 locations
NCT05858203
Inhibition of Che-1/AATF as a New Tool in Multiple Myeloma Treatment
N/A
Recruiting
150 participants
Started: Dec 22, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT04694339
Minority Barriers in Anesthesia
N/A
Recruiting
250 participants
Started: Dec 22, 2020 · Completed: Aug 31, 2026
3 conditions
2 sponsors
1 location
NCT04641143
Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
PHASE3
Active, not recruiting
700 participants
Started: Dec 22, 2020 · Completed: Nov 30, 2025
1 condition
1 sponsor
73 locations
NCT04638647
Secukinumab Open Label Roll-over Extension Protocol
PHASE4
Recruiting
715 participants
Started: Dec 22, 2020 · Completed: Apr 4, 2030
1 condition
1 sponsor
166 locations
NCT04743947
Vaccination Against COVID-19 in Chronic Kidney Disease
N/A
Recruiting
400 participants
Started: Dec 21, 2020 · Completed: Dec 31, 2025
3 conditions
1 sponsor
5 locations
Previous
1
More pages
1981
1982
1983
1984
1985
1986
1987
More pages
2369
Next